Analystreport

AzurRx BioPharma Inc (NASDAQ: AZRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.

AzurRx BioPharma, Inc.  (AZRX) 
Last azurrx biopharma, inc. earnings: 11/14 04:31 pm Check Earnings Report